Patents by Inventor Mark Dodson

Mark Dodson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8420824
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: April 16, 2013
    Assignee: Sanofi
    Inventors: Kirsten Bjergarde, Mark Dodson, Jacques Mauger, Anil Nair, Marcel Patek, Michel Tabart
  • Patent number: 8410286
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: April 2, 2013
    Assignee: Sanofi-Aventis
    Inventors: Kirsten Bjergarde, Mark Dodson, Jacques Mauger, Anil Nair, Marcel Patek, Michel Tabart
  • Publication number: 20130006246
    Abstract: A distal radius plate for repairing distal radius fractures is provided, comprising a proximal member and a distal member, wherein the proximal member includes a pair of proximal screw holes, a pair of distal screw holes; an elongated slot located between the proximal screw holes and the distal screw holes, adapted to allow placement of one or more screws within the slot; and a notch formed into the terminal end of the proximal member adapted to receive a retractor tip. The distal member is inclined with respect to the proximal member, and includes a plurality of holes for pegs and K-wires.
    Type: Application
    Filed: June 30, 2011
    Publication date: January 3, 2013
    Inventor: Mark Dodson
  • Patent number: 8058290
    Abstract: The disclosure relates to compounds of formula (I): which modulate the activity of proteins, particularly kinases, and to compositions containing the same, and to the use thereof as medicaments, in particular as anticancer agents.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: November 15, 2011
    Assignee: Aventis Pharma S.A.
    Inventors: Kirsten Bjergarde, Anil Nair, Marcel Patek, Martha Ackerman-Berrier, Martin Smrcina, Eric Bacque, Michel Tabart, Baptiste Ronan, Vincent Leroy, Fabrice Viviani, Mark Dodson, Catherine Souaille
  • Publication number: 20110237641
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Application
    Filed: June 9, 2011
    Publication date: September 29, 2011
    Inventors: Kirsten BJERGARDE, Mark DODSON, Jacques MAUGER, Anil NAIR, Marcel PATEK, Michel TABART
  • Publication number: 20110237801
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Application
    Filed: June 9, 2011
    Publication date: September 29, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Kirsten BJERGARDE, Mark DODSON, Jacques MAUGER, Anil NAIR, Marcel PATEK, Michel TABART
  • Patent number: 7989439
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: August 2, 2011
    Assignee: Sanofi-Aventis
    Inventors: Kirsten Bjergarde, Mark Dodson, Jacques Mauger, Anil Nair, Marcel Patek, Michel Tabart
  • Publication number: 20090291984
    Abstract: The disclosure relates to a compound of formula (1): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Application
    Filed: May 8, 2009
    Publication date: November 26, 2009
    Applicant: sanofi-aventis
    Inventors: Kirsten Bjergarde, Mark Dodson, Jacques Mauger, Anil Nair, Marcel Patek, Michel Tabart
  • Publication number: 20080182844
    Abstract: The disclosure relates to compounds of formula (I): which modulate the activity of proteins, particularly kinases, and to compositions containing the same, and to the use thereof as medicaments, in particular as anticancer agents.
    Type: Application
    Filed: January 29, 2008
    Publication date: July 31, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Kirsten BJERGARDE, Anil NAIR, Marcel PATEK, Martha ACKERMAN-BERRIER, Martin SMRCINA, Eric BACQUE, Michel TABART, Baptiste RONAN, Vincent LEROY, Fabrice VIVIANI, Mark DODSON, Catherine SOUAILLE